Phase I trial of TP-6076 in healthy volunteers.

Trial Profile

Phase I trial of TP-6076 in healthy volunteers.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs TP 6076 (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Most Recent Events

    • 02 Aug 2017 According to a Tetraphase Pharmaceuticals media release, the company anticipates to complete this study in the year 2017.
    • 05 Jun 2017 Results published in a Tetraphase Pharmaceuticals media release.
    • 05 Jun 2017 According to a Tetraphase Pharmaceuticals media release, the company recently initiated a multiple-ascending dose (MAD) portion of study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top